Background-After intramyocardial injection, mesenchymal stem cells (MSCs) may engraft and influence host myocardium.
D uring the past decade, stem cell therapy has been the subject of studies aiming to improve function of damaged hearts. Particularly, mesenchymal stem cells (MSCs) have been of interest in these efforts. 1, 2 Despite the fact that only low percentages of injected MSCs survive and integrate in damaged myocardium, therapeutic effects have been found in preclinical studies. 3, 4 Moreover, genetically modified MSCs have also been investigated as vehicles of biological functions, such as biological pacemakers. 5 Also, intramyocardial transplantation of bone marrow-derived cells, including human MSC (hMSCs), into diseased human myocardium has been shown to improve cardiac function. 6 These positive effects on cardiac function are thought to be mainly mediated by paracrine factors released from the transplanted cells. 7 Therefore, increasing engraftment rate to improve the therapeutic effects of transplanted cells seems a logical step and is indeed the focus of current stem cell research. 8, 9 However, the risk of adverse effects with higher engraftment rates in largely uncontrolled engraftment patterns is unknown. The number of transplanted cells that actually engraft and their distribution patterns are difficult to regulate. Few studies have focused on these aspects. Fukushima et al 10 showed that engraftment patterns of transplanted bone marrow cells may depend on administration route, ie, direct intramyocardial injection resulted in a more clustered distribution than intracoronary infusion. Such clustering may lead to formation of local conduction blocks, potentially facilitating reentrant tachyarrhythmias. Additionally, in vitro studies by Chang et al 11 have indicated that administration of hMSCs to myocardial cell cultures may indeed increase proarrhythmic risk. However, besides indirect implications that electrotonic coupling of MSCs with host cardiomyocytes may be responsible for their proarrhythmic effects, the mechanisms underlying MSC-dependent arrhythmogeneity remain unknown. Also, insights concerning differences between proarrhythmic effects of distinct engraftment profiles of MSCs are still limited. As a result, further investigation of potentially proarrhythmic actions of hMSCs is required. Such studies are especially important to improve therapeutic efficacy and to contain the hazardous potential of MSC therapy in the heart. Therefore, this study aimed to investigate the effects of engraftment characteristics of MSCs (ie, different numbers and distribution patterns) on arrhythmicity using controllable in vitro models. We found that hMSCs can indeed be proarrhythmic depending on their number and distribution pattern, and that direct contact between neonatal rat ventricular cardiomyocytes (nrCMCs) and hMSCs as well as paracrine effects of hMSCs on nrCMCs are important contributors to the proarrhythmic effects of hMSCs. The results of this study suggest that caution is warranted against potential proarrhythmic effects of MSC transplantation in cardiac tissue. The acquired knowledge about the mechanisms by which hMSCs can cause arrhythmias may help to develop strategies on how to increase the safety and efficacy of intramyocardial hMSC administration.
Materials and Methods
A more detailed description of the materials and methods can be found in the online-only Data Supplement Material, which also includes methods of immunocytological stainings, Western blot, dyetransfer, and patch-clamp experiments.
Isolation, Culture, and Characterization of hMSCs
Human tissue samples were collected after having obtained written informed consent of the donors and with the approval of the medical ethics committee of Leiden University Medical Center. The procedures used in this investigation conformed to the Declaration of Helsinki. Human MSCs were purified from leftover bone marrow samples derived from adult ischemic heart disease patients (n=4 donors). hMSCs were characterized by immunophenotyping and by their adipogenic and osteogenic differentiation potential as described in the online-only Data Supplement.
Isolation and Culture of nrCMCs
All animal experiments were approved by the animal experiments committee of the Leiden University Medical Center and conform to the Guide for the Care and Use of Laboratory Animals, as stated by the US National Institutes of Health (10236). 12 Briefly, hearts were rapidly excised from isoflurane-anesthetized animals, and the ventricles were minced into pieces and dissociated by treatment with collagenase type I (450 U/mL; Worthington Biochemical, Lakewood, NJ). The myocardial cells were preplated to minimize contamination of the nrCMC cultures with noncardiomyocytes. Purified myocardial cells were plated on fibronectin (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands)-coated coverslips in 24-wells plates (Corning Life Sciences, Amsterdam, The Netherlands) at a density of 1×4×10 5 cells/well depending on the experiment. All cultures were treated with 10 μg/mL mitomycin-C (Sigma-Aldrich Chemie) to halt proliferation of endogenous fibroblasts.
Coculture of nrCMCs and Clustered or Diffusely Spread hMSCs
To investigate the effects on arrhythmicity of myocardial engraftment of hMSCs in different patterns and doses, cocultures of nrCMCs and hMSCs were prepared. To mimic a diffuse engraftment pattern, 4.0×10 5 nrCMCs were mixed with 2.8×10 4 (7%) or 1.12×10 5 (28%) hMSCs and added onto coverslips in wells of a 24-well cell culture plate. To mimic a clustered engraftment pattern, rings with an outer diameter of 15 mm and a central inner diameter of 3 or 6 mm were lasered in Parafilm M (Bemis Company, Neenah, WI) and attached to the coverslips. Next, hMSCs were applied in these circles (3 mm: 2.8×10 4 cells or 6 mm: 1.12×10 5 cells). After attachment, the Parafilm was removed, and the attached hMSCs were overlaid with 4.0×10 5 nrCMCs.
Optical Mapping
Electrophysiological parameters were determined by optical mapping as described previously. 13 Cultures were loaded with di-4-ANEPPS (Invitrogen, Breda, The Netherlands) for 10 minutes at 37°C. Cultures were then given fresh DMEM/F12 (Invitrogen) and optically mapped using the Micam Ultima-L optical mapping system (Scimedia USA, Costa Mesa, CA).
Analysis of the Influence of Paracrine Factors on Electrophysiological Parameters of nrCMC Cultures
Mitomycin-C-treated adult hMSCs were seeded in 24-well plate transwell inserts (Corning Life Sciences). To mimic as much as possible the conditions of the nontranswell experiments, the inserts contained 2.8×10 4 or 1.12×10 5 hMSCs and were placed above 4.0×10 5 mitomycin-C-treated nrCMCs seeded on fibronectin-coated coverslips. Control cultures consisted of nrCMC cultures with no, empty, or nrCMC (1.12×10 5 cells)-filled transwell inserts. In addition, exosomes were derived from hMSCs 14, 15 and were incubated with nrC-MC cultures for 9 days.
Statistics
Experimental data were analyzed by the Mann-Whitney U test for direct comparisons, or by the Wilcoxon signed-rank test for paired observations. For multiple comparisons, the Kruskal-Wallis test with Dunn post hoc correction was used. Experimental results were expressed as mean±SD for a given number (n) of observations. Statistical analysis was performed using SPSS 16.0 for Windows (SPSS, Chicago, IL). Differences were considered statistically significant at P<0.05.
Results

Diffusely Spread hMSCs Dose-dependently Decrease Conduction Velocity and Excitability in Myocardial Cell Cultures
Adult hMSCs used in this study fulfilled established identity criteria, as shown in the online-only Data Supplement (onlineonly Data Supplement Figure SI) . The proarrhythmic effects of hMSCs were first investigated in cocultures of hMSCs and nrCMCs, in which the hMSCs were evenly distributed throughout the monolayer ( Figure 1A ). Addition of 7% or 28% hMSCs to nrCMCs dose-dependently slowed conduction from 21.6±1.8 cm/s (0% hMSCs, n=15) to 17.1±3.1 (7% hMSCs, n=20) and further to 12.6±3.2 cm/s (28% hMSCs, n=64, P<0.05 between experimental groups, Figure 1B ). Current-clamping of parallel cultures revealed a decrease in upstroke velocity in 28% hMSC-containing myocardial cell cultures (10±2 [n=5] compared with 94±10 V/s [n=7] in control cultures, P<0.05, Figure 1C and 1D). Moreover, maximal diastolic potentials were less negative for nrCMCs in coculture with 28% hMSCs (−44±5 [n=5] compared with −72±5 mV [n=7] in control cultures, P<0.05, Figure 1E and 1F). To study the effects of diffusely spread hMSCs on excitability of nrCMC cultures, conduction velocity (CV) after administration of the voltage-gated sodium channel blocker tetrodotoxin (TTX) in increments of 5 µmol/L to 20 µmol/L was measured. In cocultures containing 0% or 7% hMSCs, a TTX concentration-dependent decrease in CV was observed for the entire dose range ( Figure 1G ). However, in cultures with 28% added hMSCs, the conduction-slowing effect of TTX was saturated between 15 and 20 µmol/L (P>0.05). Moreover, the magnitude of the drop in CV by increasing TTX doses declined with increasing hMSC numbers, indicating diminished availability of Nav1.5 and thereby confirming the ability of hMSCs to decrease excitability.
hMSCs Exert Proarrhythmic Effects Through Electric Coupling With Neighboring nrCMCs
The mechanisms through which hMSCs negatively affect the excitability of nrCMCs were studied by investigating cocultures for the expression of N-cadherin, α smooth muscle actinin, and connexin-43. Adult hMSCs cocultured with nrC-MCs (n=3000 hMSCs analyzed) stained negative for α smooth muscle actinin (online-only Data Supplement Figure SIIA ). Also, no N-cadherin was present at hMSC-nrCMC junctions (online-only Data Supplement Figure SIIB ). Connexin-43 was detected at interfaces between hMSCs and nrCMCs ( Figure 2A1 ), but in lower quantities (20.2±2.2%, P<0.0001) than at nrCMC-nrCMC junctions ( Figure 2A2 ). Functional electric heterocellular coupling between hMSCs and nrCMCs was investigated by dye-transfer experiments. The enhanced green fluorescent protein-labeled hMSCs showed a significantly lower dye intensity (18.7±3.0%, P<0.001) than adjacent, calcein-loaded nrCMCs ( Figure 2B1 and B2) . Also, although a large fraction of green fluorescent protein-positive cells had taken up the dye (84.5±4.5%), not all hMSCs were positive for calcein. The lower connexin-43 levels at hMSC-nrCMC borders than at nrCMC-nrCMC interfaces were used to investigate the effect of heterocellular uncoupling by a low dose of the gap-junctional uncoupler 2-aminoethoxydiphenylborate (2-APB) on conduction in hMSC-nrCMC cocultures. After administration of 2 µmol/L 2-APB, CV in 19 cocultures of nrCMCs and 28% hMSCs rose to 133±16% of the values measured before 2-APB addition ( Figure 2C and 2D), whereas vehicle-treated (0.01% dimethyl sulfoxide, n=5) cultures showed no significant change (ie, CV after 0.01% dimethyl sulfoxide was 104±8% of CV before 0.01% dimethyl sulfoxide). 2-APB increased action potential upstroke velocity from 10±3 to 29±7 V/s (n=4, P<0.05). Furthermore, negativity of maximal diastolic potential of nrCMCs increased by 33% to −59±4 mV (P<0.05 versus without 2-APB), whereas action potential duration until 90% repolarization (APD 90 ) remained unaltered by the 2-APB treatment of the cocultures ( Figure 2E ). Importantly, treatment with 2 µmol/L 2-APB did not significantly affect any of these parameters in myocardial cell cultures lacking hMSCs (data not shown).
Diffusely Spread hMSCs Decrease Repolarization Reserve and Increase Arrhythmicity in Myocardial Cell Cultures
APD 90 was 314±61 and 379±60 ms in myocardial cell cultures containing 7% (n=24) and 28% hMSCs (n=86), respectively, compared with 221±43 ms in control cultures (n=16) ( Figure 3A and 3B). This corresponds to an hMSC dosedependent prolongation of repolarization time of 142% and 171%, respectively (P<0.05 between all groups). These findings were confirmed with patch-clamp experiments (APD 60 of 186±10 ms for nrCMCs in control cultures and of 300±21 ms in cultures with 28% added hMSCs [n=5, P<0.05]). Optical mapping showed that addition of hMSCs to myocardial cell cultures caused an increase in spatial heterogeneity of repolarization ( Figure 3C ). In control cultures, the maximal spatial difference between APD 90 values within the same culture was 65±21 ms (n=18). In cultures with 7% or 28% added hMSCs, APD 90 dispersion was 103±29 (n=13) and 181±59 ms (n=17), respectively (P<0.05, Figure 3D ).
Proarrhythmic consequences of these findings were revealed by 1 Hz stimulation, which evoked triggered activity in 14% of cultures with 28% added hMSCs (n=66, Figure 3E ). Cultures containing 7% hMSCs showed a lower incidence of triggered activity (2.6%, n=39), and triggered activity was absent in control cultures (n=39, Figure 3F ). Next, inducibility of reentrant arrhythmias was investigated by applying a burst stimulation protocol ( Figure 3G ). Re-entry was induced in 6% (n=16), 20% (n=10), and 53% (n=15) of cultures containing 0%, 7%, and 28% hMSCs, respectively ( Figure 3H ).
After confirming reproducibility of triggered activity in the same culture, the ATP-sensitive K + -channel opener P1075 was administered, which abolished all episodes of triggered activity (n=6, Figure 4A and 4B). Because P1075 strongly shortened APD 90 ( Figure 4C ) and reduced APD dispersion ( Figure  4D ) without affecting CV ( Figure 4E ), reduced repolarization reserve and steeper spatial APD gradients caused by hMSCs seem to be crucial for inducing triggered activity.
Clustered hMSCs Provide a Substrate for Re-entry in Myocardial Cell Cultures
Optical mapping of myocardial cell cultures containing a central cluster of hMSCs revealed local slowing of conduction to 4.7±1.6 and 5.4±1.3 cm/s in hMSC clusters with a diameter of 3 mm (n=21) and of 6 mm (n=20), respectively (P=NS), whereas CV outside these clusters remained as high as in control cultures (22.2±1.7 and 22.4±1.8 compared with 22.4±2.3 cm/s, P=NS, Figure 5A -5C). APD 90 was prolonged inside the 3-mm hMSC clusters (333±30 compared with 254±58 ms outside, P<0.05) and inside the 6-mm hMSC clusters (343±48ms compared with 310±40 ms outside, P<0.05, Figure 5D -5G). Because of these local effects, APD 90 dispersion was also increased in cultures with a 3-or 6-mm cluster of hMSCs ( Figure 5D ). Interestingly, APD 90 in the ring of nrCMCs around 6-mm hMSC clusters was significantly prolonged (310±40 ms) compared with that in control cultures (245±61 ms) or in the ring of nrCMCs around 3-mm hMSC clusters (254±58 ms, P<0.05 versus all, Figure 5F -5G). No triggered activity was observed in any of these cultures. However, burst stimulation induced re-entry in 6% of the control cultures (n=16), and in 14% (n=22) and 23% (n=30) of the cultures with 3-and 6-mm central clusters of hMSCs, respectively ( Figure 5H-5J ). Induced reentrant arrhythmias anchored to the hMSC clusters.
hMSCs Release Free Paracrine Factors That Prolong Repolarization but Do Not Affect Conduction
To study a possible paracrine contribution 16 to hMSC-induced APD prolongation, transwell experiments were conducted. Transwells with inserts containing 0%, 7%, or 28% hMSCs had almost identical CVs of 21.9±0.9, 22.3±1.3, and 22.9±0.7 cm/s, respectively (P=NS). Additionally, the conductionslowing effect of TTX was very similar for transwell cultures containing different numbers of hMSCs (P>0.05, Figure 6A ). However, APD 90 was dose-dependently affected by hMSCs, because APD 90 was 227±35 ms for controls (n=38) as compared with 300±91 and 362±88 ms for transwells with inserts containing 7% hMSCs (n=46) and 28% hMSCs (n=45), respectively (P<0.05, Figure 6B ). Dispersion of repolarization showed a similar positive relation with hMSC numbers, with APD 90 dispersion values of 78±23, 105±50 and 148±72 ms for transwells whose inserts contained 0%, 7% and 28% hMSCs ( Figure 6C ). None of the transwell cultures displayed triggered activity. However, inducibility of re-entry was slightly increased from 14% (n=29) in controls to 16% (n=44) and 24% (n=38) for transwells with 7% and 28% of hMSCs, respectively ( Figure 6D ). Patch-clamp experiments also showed a prolonged APD in nrCMCs exposed to the secretome of 28% hMSCs (335±6 ms, n=4) compared with unexposed CMCs (193±7 ms, n=4, P<0.05, Figure 7A and 7B). However, dV/dt max (104±7 V/s versus 107±9 V/s in controls, P=0.72, Figure 7C ) and resting membrane potential (−68±4 mV versus −67±3 mV in controls, P=0.72) were unaffected by the hMSC secretome. Western blot analysis of ion channel protein levels in nrCMCs exposed to the hMSC secretome of 28% hMSCs revealed lower levels of Cav1.2 (0.43±0.01 versus 0.22±0.04 arbitrary units, P<0.05) and Kv4.3 (0.26±0.04 versus 0.22±0.04 arbitrary units, P<0.05), whereas the Kir2.1 level was not significantly altered (0.30±0.03 versus 0.27±0.05, P>0.05, Figure 7D ).
To investigate whether exosomes (ie, microvesicles secreted by mammalian cells containing instructive molecules, including cytokines, mRNAs, and microRNAs) were responsible for these effects, exosomes from the hMSC secretome (representing 28% hMSCs) were added to pure nrCMC cultures and refreshed every 2 days ( Figure 8A ). At day 9, optical mapping did not reveal any changes in APD 90 ( Figure 8B ) or CV ( Figure 8C ) by adding hMSC-derived exosomes to nrCMC cultures, suggesting that the effect of the hMSC secretome on APD prolongation is primarily mediated by directly secreted 
Discussion
This study has shown that (1) adult bone marrow-derived hMSCs contribute to APD dispersion, triggered activity, and reentrant tachyarrhythmias in neonatal rat myocardial cell cultures; (2) the proarrhythmic effects of hMSCs are mediated by 2 separate mechanisms, that is, functional coupling of hMSCs with adjacent nrCMCs, resulting in partial nrCMC depolarization, and conduction slowing, and paracrine signaling of hMSCs to neighboring nrCMCs that slows nrCMC repolarization; and (3) the number and distribution pattern of the MSCs in the myocardial cell cultures determine the type and severity of the arrhythmias.
Effect of hMSC Transplantation on Cardiac Electrophysiology
Whether and how cardiac cell therapy may increase the risk of ventricular arrhythmias remain topics of debate. [17] [18] [19] [20] Gap-junctional coupling between transplanted cells and host cardiomyocytes seems to be essential for functional electric integration, thereby preventing an increase in electric heterogeneity, leading to arrhythmias. 21 Other studies have emphasized the role of cell alignment in electric integration of transplanted cells in recipient myocardium and the potential proarrhythmic consequences of malalignment. 22 The number and distribution of donor cells in the host myocardium may also affect their arrhythmogenic potential. 11 However, very little is known about cell therapy-associated proarrhythmic mechanisms.
The current study demonstrates that both evenly spread and clustered hMSCs can exert proarrhythmic effects in myocardial cell cultures in a dose-dependent manner. However, the types of evoked arrhythmias depended on hMSC distribution pattern. By applying the hMSCs in a diffuse pattern, interactions with surrounding nrCMCs are maximized leading to increases in triggered activity and induced re-entry incidence, whereas in myocardial cell cultures containing central clusters of hMSCs, only the propensity toward re-entry was increased. Triggered activity in diffuse cocultures was associated with decreased repolarization reserve because APD shortening by opening of ATP-sensitive K + -channels abolished such episodes, which together with pseudoelectrogram morphology points to early afterdepolarizations as likely cause of triggered activity. Because the P1075-treated cultures did not show any triggered activity, the concomitant APD shortening by P1075 did not lead to increased re-entry incidence. 23 The mechanism of early afterdepolarizations is considered to be reactivation of L-type calcium channels that linger within the window current because of a decreased repolarizing force. 23 Because this mechanism is based on a highly complex and delicate balance between depolarizing and repolarizing forces that depends on activation and deinactivation mechanics of ion channels, the absence of triggered activity in myocardial cell cultures containing clustered hMSCs can be explained by hMSC densitydependent skewing of action potential dynamics beyond the window current. The notion of density-dependent proarrhythmic effects of hMSCs is supported by findings of differences in CV and APD inside the 6-mm hMSC clusters in comparison with equal amounts of more diffusely integrated hMSCs. As hMSC clusters formed local zones of conduction delay and refractoriness, the cluster size-dependent increase in inducibility of re-entry is most likely attributable to the increased possibility of spiral wave anchoring with increasing obstacle sizes. 24 Higher inducibility of re-entry in cultures with diffusely spread hMSCs than in those containing clustered hMSCs indicates stronger proarrhythmic effects of widespread than of locally concentrated hMSC-nrCMC interactions.
Role of Heterocellular Coupling in Conduction Slowing by hMSCs
Conduction slowing is widely recognized as a proarrhythmic feature that increases the probability of wavefront collision, partial conduction block, and spiral wave formation. 23 In an earlier study, Chang et al 11 revealed that hMSCs slow conduction in myocardial cell cultures, presumably by electrotonic heterocellular interactions. Two other studies showed the ability of hMSCs to overcome local conduction blocks by functional coupling to nrCMCs, and passively and slowly conducting action potentials. 25, 26 In the present study, we confirmed slowed conduction by hMSCs in myocardial cell cultures without anatomic conduction block. Importantly, hMSCs were shown to reduce nrCMC excitability, because dV/dt max and TTX sensitivity were decreased. Treatment of diffuse cocultures with low doses of the gap-junctional uncoupler 2-ABP indicated that heterocellular coupling was the dominant mechanism responsible for the conduction-slowing effect of hMSCs. Although 2-APB, as most pharmacological agents, has other known effects, 27, 28 these effects occur at higher dosages and cannot account for the increase in CV observed in Figure 2D . Partial heterocellular uncoupling increased CV in cocultures, and nrCMCs showed a more negative maximal diastolic potential and a higher action potential upstroke velocity, which are all indicative of partially restored excitability. 29 Heterocellular mechanical coupling was also investigated in the current study. Myofibroblasts were recently shown to exert proarrhythmic effects by providing a noncompliant mechanical resistance through their rigid cytoskeleton, which contains large amounts of α smooth muscle actinin and may thereby activate stretch-activated ion channels in nrCMCs. 30, 31 However, the adult hMSCs used in this study did not express α smooth muscle actinin or N-cadherin in cocultures with nrC-MCs, which makes it unlikely that mechanical coupling plays a major role in hMSC-associated conduction slowing and arrhythmicity.
Role of Paracrine Signaling in Repolarization Slowing and Dispersion by hMSCs
In cardiac arrhythmogenesis, prolonged repolarization times and dispersion of repolarization are considered crucial proarrhythmic factors for triggered activity and reentrant tachyarrhythmias. 23 Interestingly, although experiments with commercially obtained hMSCs reported no effect of these cells on repolarization or the incidence of triggered activity, 11 the present study provides evidence that clinically used hMSCs from ischemic heart disease patients in coculture with nrCMCs can prolong repolarization time, increase repolarization dispersion, and promote triggered activity, which is likely to be caused by spatial repolarization gradient steepening. 23 The mechanism of decreased repolarization reserve was elusive at first. In contrast to the effects of heterocellular uncoupling between nrCMCs and myofibroblasts, 32 decreasing heterocellular coupling between hMSCs and nrCMCs did not affect APD. However, it is becoming increasingly evident that the hMSC is a cell type with high paracrine activity that secretes a wide variety of directly secreted and exosome/microvesicle-associated factors associated with reverse remodeling, and anti-inflammatory and proangiogenic activity. [33] [34] [35] These findings combined with the APD prolongation at the periphery of cocultures containing clustered hMSCs, where there is no physical contact between hMSCs and nrCMCs, raised the possibility that paracrine rather than electrotonic mechanisms are responsible for the decreased repolarization reserve. Indeed, experiments with hMSCs in transwell inserts, to allow passage of the hMSC secretome without physical contact between hMSCs and nrCMCs, revealed hMSC dose-dependent increases in APD, dispersion of repolarization, and inducibility of re-entry in the nrCMCs seeded on the bottom of the transwell. Because hMSC-derived exosomes did not significantly affect nrCMC APD, it is likely that APD prolongation in our model was based on directly secreted paracrine factors. Loss of biological activity of exosomes is unlikely, because they were purified using established procedures. 14, 15 The current study has not provided any indication of proarrhythmic effects of exosomes purified from hMSC cultures. Because exosomes may have a significant contribution to the therapeutic effects caused by the paracrine activity of MSCs, they might therefore represent a safer alternative to cell therapy for improving heart function. 16, 36 Paracrine activity of hMSCs has been associated with beneficial effects in in vivo models of cardiac remodeling. 33 A common feature of these models was the low-engraftment rate of the hMSCs. As suggested in this study, higher hMSC engraftment rates might lead to increased production of paracrine factors, tipping the balance from beneficial to adverse effects. Interestingly, paracrine signaling did not alter conduction or excitability, because the sensitivity of CV to Nav1.5 blockade by TTX remained the same between myocardial cell cultures exposed to the secretome of 0%, 7%, or 28% hMSCs. It did, however, change the ion channel levels as revealed by Western blot analyses. In particular, Cav1.2 and Kv4.3 levels were significantly lowered by exposure to the hMSC secretome. Whereas decreased Cav1.2 expression would theoretically shorten APD, lowered Kv4.3 expression prolongs APD by decreasing I to . 37 Because APD prolongation was found both in optical mapping and patch-clamp experiments, the effect of lowered Kv4.3 expression seemed to be dominant in our cultures. The Kir2.1 level was not significantly altered in nrCMCs cultured below hMSC-containing transwell inserts, which is consistent with findings of intact excitability of nrC-MCs exposed to the hMSC secretome. Although functional effects of altered ion channel expression are likely, more research is needed to be certain, because paracrine factors may also modulate the activity of proteins involved in cardiac impulse propagation by direct binding to these proteins or by inducing their post-translational modification. For example, a recent study by Desantiago et al 38 showed that MSCs are able to increase I CaL through the phosphatidylinositol 3-kinase/Akt pathway. Pinpointing the paracrine factors that are responsible for the proarrhythmic effects observed in our study and unraveling their mechanisms of action are subjects of future studies. The findings of the current study may raise cautionary concerns regarding the use of genetically modified MSCs as biological pacemakers. 5 Such an approach relies on the premise that MSCs are electrically inert, other than their ability to couple to surrounding cells and achieve automaticity by electrotonic interactions. If MSCs modulate electric behavior via secreted factors, then using MSCs as pacemakers may have unintended APD prolonging effects and may increase the proarrhythmic risk.
Study Limitations
Because of ethical and technical limitations, cardiomyocytes of human adults could not be not investigated in this study. As an alternative, nrCMCs were used, because these cells are available in large amounts and can be maintained in culture as contractile monolayers for the time period needed for mechanistic studies on stem cell engraftment. However, their ion channel expression profile and distribution of gap junctions differ from those of human adult CMCs. Therefore, the comparability of neonatal rat CMCs with adult and clinical situations may be limited. Nevertheless, 2-dimensional in vitro models of rat myocardial tissue have shown to be relevant for studying cardiac electrophysiology, by mimicking key electrophysiological processes in the intact heart. 39 Because the current model used healthy nrCMCs, the implications of current findings for disease models for stem cell therapy need to be investigated in future studies. To assess the consequences of this study for hMSC transplantation in the heart, our findings should be considered in the context of 3-dimensional, anisotropic myocardium.
Conclusion
In myocardial cell cultures, adult hMSCs slow conduction, prolong repolarization, increase spatial dispersion of repolarization, and cause triggered activity and reentrant arrhythmias by different mechanisms. Electrotonic coupling of hMSCs to nrCMCs reduces excitability and thereby CV, whereas the paracrine factors that are directly secreted by hMSCs slow nrCMC repolarization. Thus, caution is warranted against potential proarrhythmic effects of MSC transplantation in cardiac tissue. The observation that the proarrhythmic activity of hMSCs in cocultures with nrCMCs is strongly influenced by their number and distribution suggests that by controlling MSC engraftment rate and patterns the critical balance between therapeutic potential and hazardous risk of MSC therapy for cardiac diseases may be tipped in the right direction.
CLINICAL PERSPECTIVE
Although preclinical research has shown that relatively few transplanted stem cells engraft in damaged myocardium, small but significant beneficial effects of stem cell therapy on heart function have been observed in the clinic. Consequently, strategies are being developed to increase stem cell engraftment rates to magnify therapeutic effects. However, myocardial transplantation of adult, inexcitable stem cells could theoretically increase proarrhythmic risk. Little is known about the role of engraftment rate and pattern in the potential proarrhythmic effects of cardiac cell therapy, because these are difficult parameters to regulate in vivo. Therefore, we used an in vitro model of clustered and diffuse engraftment of adult human mesenchymal stem cells (hMSCs). Importantly, we found that hMSCs exert dose-dependent proarrhythmic effects on cardiomyocytes through electrotonic modulation of excitability and paracrine prolongation of repolarization time. The beneficial effects of hMSCs in damaged hearts seem mainly mediated by paracrine mechanisms. Therefore, our in vitro findings of proarrhythmic prolongation of repolarization time by such a mechanism advise caution against uncontrolled increase in hMSC engraftment. Interestingly, the paracrine effects were likely to be mediated by directly secreted paracrine factors instead of exosomes. The implications of these findings could be important, because recent evidence suggests that exosomes are responsible for a large portion of the therapeutic effects of MSCs. Therefore, in certain cases, exosome therapy may be considered as a safer alternative to cell therapy for treatment of cardiac diseases, because proarrhythmic effects related to cell engraftment are circumvented, although more detailed and mechanistic studies are needed.
